Skip to main content

Advertisement

SpringerLink
Log in

Albumin microspheres as carriers for the antiarthritic drug celecoxib

  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

The present study investigates the preparation of celecoxib-loaded albumin microspheres and the biodistribution of technetium-99m (99mTc)-labeled celecoxib as well as its microspheres after intravenous administration. Microspheres were prepared using a natural polymer BSA using emulsification chemical cross-linking method. The prepared microspheres were characterized for entrapment efficiency, particle size, and in vitro drug release. Surface morphology was studied by scanning electron microscopy. Biodistribution studies were performed by radiolabeling celecoxib (CS) and its microspheres (CMS) using99mTc and injecting arthritic rats intravenously. The geometric mean diameter of the microspheres was found to be 5.46 μm. In vitro release studies indicated that the microspheres sustained the release of the drug for }6 days. Radioactivity measured in different organs after intravenous administration of celecoxib solution showed a significant amount of radioactivity in the liver and spleen. In case of celecoxib-loaded microspheres, a significant amount of radioactivity accumulated in the lungs. No significant difference (P>.1) in the radioactivity was observed between the inflamed joint and the noninflamed joint following intravenous injection of99mTc-CS. However, in case of the microspheres (CMS), the radioactivity present in the inflamed joint was 2.5-fold higher than in the noninflamed joint. The blood kinetic studies revealed that celecoxib-loaded albumin microspheres exhibited prolonged circulation than the celecoxib solution.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bogdansky S. Natural polymers as drug delivery systems. In: Chasin M, Langer R, eds.Biodegradable Polymers as Drug Delivery Systems. New York, NY: Marcel Dekker Inc; 1990:231–259.

    Google Scholar 

  2. Kramer PA. Albumin microspheres as vehicles for achieving specificity in drug delivery.J Pharm Sci. 1974;63:1646–1647.

    Article  CAS  Google Scholar 

  3. Bernard NG, Shaw SM, Kessler WV, Landolt RR, Peck GE, Dockerty GH. Distribution and degradation of I-125 albumin microspheres and technetium 99m sulphur colloid.J Pharm Sci. 1980;15:30–34.

    Google Scholar 

  4. Schafer V, Briesen H, Rubsamen-Waigman H, Steffan AM, Royer C, Kreuter J. Phagocytosis and degradation of human serum albumin microspheres and nanoparticles in human macrophages.J Microencapsul. 1994;11:261–269.

    Article  CAS  Google Scholar 

  5. Müller BG, Leuenberger H, Kissel T. Albumin nanospheres as carriers for passive drug targeting: an optimized manufacturing technique.Pharm Res. 1996;13:32–37.

    Article  Google Scholar 

  6. Tomilson E, Burger JJ, Schoolderwoerd EMA, McVie JG. Human serum albumin microspheres for intra-arterial drug targeting of cytostatic compounds. In: Davis SS, Ilium JG, eds.Microspheres and Drug Therapy. Amsterdam, The Netherlands; Elsevier; 1984:75–91.

    Google Scholar 

  7. Tomilson E, Burger JJ. Monolithic albumin particles as drug carriers. In: Illum L, Davis SS, eds.Polymers in Controlled Drug Delivery. Bristol, UK: IOP Publishing Limited; 1987:25–48.

    Google Scholar 

  8. Wunder A, Muller-Ladner U, Stelzer EH, et al. Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis.J Immunol. 2003;170:4793–4801.

    CAS  Google Scholar 

  9. Breton J, Pezzi N, Molinari A, et al. Prolonged half-life in the circulation of a chemical conjugate between a pro-urokinase derivative and human serum albumin.Eur J Biochem. 1995;231:563–569.

    Article  CAS  Google Scholar 

  10. Srinath P, Chary MG, Vyas SP, Diwan PV. Long-circulating liposomes of indomethacin in arthritic rats: a biodisposition study.Pharm Acta Helv. 2000;74:399–404.

    Article  CAS  Google Scholar 

  11. Metselaar JM, Wauben MH, Wagenaar-Hilbers JP, Boerman OC, StorM G. Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes.Arthritis Rheum. 2003;48:2059–2066.

    Article  CAS  Google Scholar 

  12. Corvo ML, Boerman OC, Oyen WJ, et al. Intravenous administration of superoxide dismutase entrapped in long circulating liposomes. II. In vivo fate in a rat model of adjuvant arthritis.Biochim Biophys Acta. 1999;1419:325–334.

    Article  CAS  Google Scholar 

  13. Perazella MA, Eras J. Are selective COX-2 inhibitors nephrotoxic?Am J Kidney Dis. 2000;35:937–940.

    Article  CAS  Google Scholar 

  14. Bing RJ. Cyclooxygenase-2 inhibitors: is there an association with coronary or renal events?Curr Atheroscler Rep. 2003;5:114–117.

    Article  Google Scholar 

  15. Brater DC. Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition.Am J Med 1999;107(6A):65S-70S; discussion 70S–71S.

    Article  CAS  Google Scholar 

  16. Tacconelli S, Capone ML, Patrignani P. Clinical pharmacology of novel selective COX-2 inhibitors.Curr Pharm Des. 2004; 10:589–601.

    Article  CAS  Google Scholar 

  17. Alper AB Jr, Meleg-Smith S, Krane NK. Nephrotic syndrome and interstitial nephritis associated with celecoxib.Am J Kidney Dis. 2002;40:1086–1090.

    Article  Google Scholar 

  18. Lewis DA, Field WN, Hayes K, Alpar HO. The use of albumin microspheres in the treatment of carageenan-induced inflammation in the rat.J Pharm Pharmacol. 1992;44:271–274.

    CAS  Google Scholar 

  19. Alpar HO, Field WN, Hyde R, Lewis DA. The transport of microspheres from the gastrointestinal tract to inflammatory air pouches in the rat.J Pharm Pharmacol. 1989;41:194–196.

    CAS  Google Scholar 

  20. Tuncay M, Calis S, Kas HS, Ercan MT, Peksoy L, Hincal A. Diclofenac sodium incorporated PLGA (50:50) microspheres: formulation considerations and in-vitro/in-vivo evaluation.Int J Pharm. 2000;195(1–2):179–188.

    Article  CAS  Google Scholar 

  21. Richardson VJ, Jeyashingh K, Jewkes RF. Properties of [99mTc] labeled liposomes in normal and tumor bearing rats.Biochem Soc Trans. 1977;5:290–291.

    CAS  Google Scholar 

  22. Theobald AE. Quality Control of Radiopharmaceuticals. In: Sampson CB, ed.Textbook of Radiopharmacy: Theory and Practice. New York, NY: Gordon and Breach Science Publishers; 1990:127–129.

    Google Scholar 

  23. Vogel GH, Vogel WH. Anti-athoratic and immunomodulatory activity. In:Drug Discovery and Evaluation-Pharmacological Assays. Berlin, Germany: Springer Verlag; 1997:421–460.

    Google Scholar 

  24. Wu MS, Robbins JC, Bugianesi RL, Ponpipom MM, Shen TV. Modified in vivo behavior of liposomes containing synthetic glycolipids.Biochim Biophys Acta. 1981;674:19–29.

    CAS  Google Scholar 

  25. Sahin S, Selek H, Ponchel G, et al. Preparation, characterization and in vivo distribution of terbutaline sulfate loaded albumin microspheres.J Control Release. 2002;82:345–358.

    Article  CAS  Google Scholar 

  26. Jameela SR, Kumary TV, Lal AV, Jayakrishnan A. Progesterone loaded chitosan microspheres: a long acting biodegradable controlled delivery system.J Control Release. 1998;52:17–24.

    Article  CAS  Google Scholar 

  27. United States Pharmacopeial Convention. Glutaral disinfectant solution. In:United States Pharmacopoeia XXII National Formulary XVII. Rockville, MD: United States Pharmacopeial Convention; 1990:1934.

    Google Scholar 

  28. Wunderlich G, Pinkert J, Andreeff M, et al. Preparation and biodistribution of rhenium-188 labeled albumin microspheres: a promising new agent for radiotherapy.Appl Radiat Isot. 2000;52:63–68.

    Article  CAS  Google Scholar 

  29. Rhodes BA, Zölle I, Buchanan JW, Wagner HN. Radioactive albumin microspheres for studies of the pulmonary circulation.Radiology. 1969;92:1453–1460.

    CAS  Google Scholar 

  30. Lee TK, Sokoloski TD, Royer GP. Serum albumin beads: an injectable biodegradable system for the sustained release of drugs.Science. 1981;213(4504):233–235.

    Article  CAS  Google Scholar 

  31. Komaki R, Liao Z, Milas L. Improvement strategies for molecular targeting: cyclo-oxygenase-2 inhibitors as radiosensitizers for non-small cell lung cancer.Semin Oncol. 2004;31:47–53.

    Article  CAS  Google Scholar 

  32. Cuzzocrea S, Mazzon E, Sautebin L, et al. Protective effects of celecoxib in lung injury and red blood cells modification induced by carageenan in the rat.Biochem Pharmacol. 2002;63:785–795.

    Article  CAS  Google Scholar 

  33. Cerchietti LC, Navigante AH, Peluffo GD, et al. Effects of celecoxib, medroxyprogesterone, and dietary intervention on systemic syndromes in patients with advanced lung adenocarcinoma: a pilot study.J Pain Symptom Manage. 2004;27:85–95.

    Article  CAS  Google Scholar 

  34. Diperna CA, Bart RD, Sievers EM, Ma Y, Starnes VA, Bremner RM. Cyclooxygenase-2 inhibition decreases primary and metastatic tumor burden in a murine model of orthotopic lung adenocarcinoma.J Thorac Cardiovasc Surg. 2003;126:1129–1133.

    Article  CAS  Google Scholar 

  35. Peluffo GD, Stillitani I, Rodriguez VA, Diament MJ, Klein SM. Reduction of tumor progression and paraneoplastic syndrome development in murine lung adenocarcinoma by nonsteroidal anti-inflammatory drugs.Int J Cancer. 2004;110:825–830.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Drug Delivery Laboratory, Centre of Relevance and Excellence in New Drug Delivery system Pharmacy Department, Donor's Plaza, Opposite to University main office, MS University of Baroda, Fatehgunj, 390 002, Vadodara, India

    Hetal Thakkar, Rakesh Kumar Sharma & Rayasa Ramchandra Murthy

  2. Division of Radiopharmaceuticals and Radiation Biology, Institute of Nuclear Medicine and Allied Sciences, Brig SK Mazumdar Road, 110 054, Delhi, India

    Anil Kumar Mishra & Krishna Chuttani

Authors
  1. Hetal Thakkar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rakesh Kumar Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anil Kumar Mishra
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Krishna Chuttani
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rayasa Ramchandra Murthy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rayasa Ramchandra Murthy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thakkar, H., Sharma, R.K., Mishra, A.K. et al. Albumin microspheres as carriers for the antiarthritic drug celecoxib. AAPS PharmSciTech 6, 12 (2005). https://doi.org/10.1208/pt060112

Download citation

  • Received:

  • Accepted:

  • DOI: https://doi.org/10.1208/pt060112

Keywords

Search

Navigation